tetrachlorodibenzo-p-dioxin (TCDD) and was found to also be Expression of the Ah receptor-regulated cytochrome inducible in primary cultures of human epidermal keratinocytes P4501B1 (CYP1B1) gene was studied in human adult and
(1). CYP1B1 mRNA was detected in several human tissues fetal tissues and cells in culture by reverse transcriptaseby RNA blotting (1). Metabolic activity and immunoreactivity coupled polymerase chain reaction (RT-PCR). In adults, with anti-murine CYP1B1 antibody suggest that CYP1B1 is CYP1B1 mRNA was detected in liver, lymphocytes, cells of constitutively expressed in the human breast cancer cell line bronchoalveolar lavage samples and uterine endometrium, MCF-7 and in uterine myometrium and myoma tissues (7, 8) .
but not in lung. The level of expression was very low in
In a recent study CYP1B1 was also identified in human breast adult liver and only three out of six fetal livers expressed tumors (9).
CYP1B1. Extrahepatic fetal tissues, especially brains and
Endocrine glands have been shown to be the major sites of kidneys, expressed high levels of CYP1B1. CYP1B1 mRNA CYP1B1 expression in experimental animals (10) . Human was constitutively detected at a low level in first trimester placenta is an important endocrine organ during pregnancy and full-term placental samples. A competitive RT-PCR and produces notable amounts of estrogens. In placenta, assay was developed to assess the regulation of CYP1B1.
estradiol is hydroxylated predominantly at C-2 by aromatase CYP1B1 mRNA was not induced in placenta by maternal (CYP19) (11), while constitutive 4-hydroxylation is only a cigarette smoking. Inducibility of CYP1B1 in cells in culture minor pathway (7) . Maternal smoking, however, preferentially by the Ah receptor ligand 2,3,7,8-tetrachlorodibenzo-pincreases placental 4-hydroxylation, concomitantly with dioxin was studied in primary fibroblasts and chorion increased aryl hydrocarbon hydroxylase (AHH) activity (12) . carcinoma cell line JEG-3 having different CYP1A1 inducCigarette smoke strongly induces CYP1A1 in human placenta. tion properties. Inducibility of CYP1B1 was found to be This enzyme mainly 2-hydroxylates estradiol and has very regulated independently from CYP1A1. In JEG-3 cells little 4-hydroxylase activity (13) . Several lines of evidence CYP1A1 mRNA was induced up to 9000-fold, while the suggest that CYP1B1 mediates estradiol 4-hydroxylation (6,7). expression of CYP1B1 was not affected. Expression of Ah CYP1B1 could therefore potentially be the inducible placental receptor and Ah receptor nuclear translocator (regulators estradiol 4-hydroxylase. of the CYP1 family) was determined in human placenta Induction of members in the CYP1 family is controlled by and in the JEG-3 cell line. Expression of these transcription the aryl hydrocarbon receptor (Ah receptor) and Ah receptor factors was found neither to be co-regulated nor affected nuclear translocator (ARNT). The Ah receptor has been shown by Ah receptor ligands. This study provides evidence that to be expressed abundantly in human placenta (14,15). Howin addition to the Ah receptor complex, other cell-specific ever, individual variations in the expression level of placental factors modulate the response of CYP1B1 and CYP1A1 to Ah receptor and its relation to ARNT has not been elucidated.
Ah receptor ligands.
In the present study we have characterized, using qualitative and quantitative reverse transcriptase-polymerase chain reaction (RT-PCR): (i) constitutive expression of the CYP1B1 gene Introduction in human adult and fetal tissues; (ii) the relationship between CYP1A1 and CYP1B1 induction; (iii) CYP1B1 induction by A new member of human cytochrome P450 (CYP*) family 1 cigarette smoke in placenta in vivo; (iv) placental expression was recently identified (1) and designated CYP1B1 according and regulation of the CYP1 family regulating factors Ah receptor and ARNT. Fig. 1 . Detection of CYP1B1 in fetal tissues and adult liver by RT-PCR. All the samples used for mRNA extraction were prepared from macroscopically PCR products were transferred to nylon filters and hybridized with a 32 Pnormal tissues. The use of fetal tissues and surplus tissues from surgery was labeled CYP1B1 cDNA probe. FK, fetal kidney (n ϭ 3); FB, fetal brain approved by the Ethics Committees of the participating institutions.
(n ϭ 2); FLu, fetal lung (n ϭ 6); NC, negative control; AL, adult liver Cell culture (n ϭ 8); FA, fetal adrenal (n ϭ 4); FL, fetal liver (n ϭ 6). Human choriocarcinoma cell line JEG-3 was a kind gift from Dr Reijo Vihko (Department of Clinical Chemistry, University of Oulu, Finland). Human primary fibroblast cells derived from an oral mucous membrane sample Group FASTA program. An aliquot of 1 µl cDNA (out of 15 µl total) was used in each PCR reaction, containing 2 U DynaZyme DNA polymerase obtained during a dental operation were provided by Dr Tuula Salo (Department of Dentistry, University of Oulu, Finland). JEG-3 and primary fibroblasts (Finnzymes, Helsinki, Finland), 5 µl 10ϫ DynaZyme reaction buffer, dNTP reaction mix (Finnzymes) at a final concentration of 200 µM, 50 pmol each (passage Ͻ15) were cultured in Dulbecco's modified Eagle's medium nutrient mix F-12 supplemented with 10% (v/v) fetal bovine serum and gentamicin primer and water to a final volume of 50 µl. The reaction mixture was preheated at 94°C for 9 min and 35 PCR cycles were performed: 1 min at (50 µg/ml). Cells were cultured under standard conditions at 37°C, 5% CO 2 and saturated humidity. Nearly confluent cells were incubated with varying 94°C, 1 min at 58°C, 2 min at 72°C. In every series of PCR reactions there was a negative control containing a cDNA synthesis reaction performed with concentrations of TCDD or the respective volume of dimethylsulfoxide for 24 h. TCDD was obtained from the National Cancer Institute Chemical previously heat-inactivated reverse transcriptase enzyme. After the PCR reaction, 8 µl of reaction mixture were electrophoresed in an agarose gel and Carcinogen Repository (Bethesda, MD). After a 24 h exposure, cells were washed twice with phosphate-buffered saline (PBS) and either collected into stained with ethidium bromide. A visible band of expected size (310 bp) in the agarose gel was considered as a sign of gene expression. All PCR reactions a small volume of lysis buffer for RNA extraction or into PBS for enzymatic assays. All the cell culture experiments were repeated once to ensure were repeated at least once. To ensure the identity of the PCR products, amplified DNA was transferred to a Qiabrane nylon filter (Qiagen, Chatsworth, reproducibility. All cell culture reagents were from Gibco BRL (Roskilde, Denmark).
CA) and hybridized under stringent conditions with a 32 P-labeled CYP1B1 cDNA probe (Figure 1 ). RNA and cDNA cDNA probes Total placental RNA was extracted with guanidium thiocyanate followed by centrifugation in cesium chloride. From all other tissues and all cultured cells cDNA probes for CYP1B1, ARNT and Ah receptor were prepared by amplifying~1000 bp long products from cDNA prepared from human placental mRNA was extracted with a QuickPrep Micro mRNA Purification Kit (Pharmacia Biotech, Vantaa, Finland).
RNA. The PCR products were subsequently cloned into the pCRII vector (TA-cloning Kit; Invitrogen, San Diego, CA) and sequenced to verify Because the genomic structure of CYP1B1 is not yet available, we were unable to target the primers to separate exons. Therefore the complete removal their correct identities. CYP1A1 cDNA probe was prepared as described previously (17). of genomic DNA from RNA was essential for the assay. RNA was treated with RNase-free DNase I (Pharmacia Biotech) and the DNase was removed Quantitative PCR by phenol/chloroform/isoamyl alcohol extraction followed by a second extracCompetitive PCR controls for CYP1A1, CYP1B1, Ah receptor and ARNT tion with chloroform/isoamyl alcohol and ethanol precipitation. Afterwards, were prepared according to Jin et al. (18) . The basis of this method is PCR all the RNA samples were verified by PCR to be free of any contaminating amplification of a part of the target sequence with the same 3Ј primer and a genomic DNA.
recombinant 5Ј primer to produce a shortened template that can be amplified cDNA was synthesized with a First-Strand cDNA Synthesis Kit (Pharmacia by the original primer pair (Table I ). The obtained PCR products, containing Biotech, Vantaa, Finland) using pd(N) 6 random hexadeoxynucleotides. Alia small 50-70 bp deletion but otherwise being identical in sequence to the quots of 5 µg total RNA or 1 µg mRNA were used in each synthesis. cDNAs target templates, were then cloned into the pCRII vector (TA-cloning Kit; were stored at -20°C until PCR amplifications were performed. The integrity Invitrogen). of all cDNA preparations was verified by PCR amplification of transcripts Quantitation was performed as follows. A master mix of the PCR reagents known to be expressed in each tissue.
(2 U DynaZyme DNA polymerase, 5 µl 10ϫ DynaZyme reaction buffer, RT-PCR dNTP reaction mix at a final concentration of 200 µM, 50 pmol each primer and water to a final volume of 48 µl) was aliquoted into sample tubes and a RT-PCR was performed essentially as described earlier (16) . The primers (Table I) were designed to hybridize only to the desired regions of cDNA. To constant amount of the studied cDNA along with a serial dilution of control plasmid was added to the reactions. Thirty five PCR cycles were performed exclude the chances of cross-hybridization with other sequences, each primer was compared with the EMBL human gene bank with the Genetics Computer as described in the previous paragraph. Every seventh tube was a negative
All the placenta samples, from both the first trimester of pregnancy and full-term, had detectable CYP1B1 mRNA (Table II) . CYP1B1 appeared to be constitutively expressed with no great differences between smokers and non-smokers.
Quantitative determination of CYP1B1 in placenta
Conventional RNA blotting was performed with several placental samples from both smoking and non-smoking mothers. No CYP1B1 mRNA, however, was detected with extended autoradiography times of up to 2 weeks (data not shown). Therefore, a quantitative RT-PCR method was developed as described.
Four full-term placentas with a well-characterized CYP1A1 status (17) were chosen for quantitative determinations. Placentas 91/3 and 91/4 were from non-smoking mothers and had uninduced CYP1A1 as measured by RT-PCR, immunoblotting have been shown to be non-responsive (24) .
Enzyme assays
Both the CYP1A1 and CYP1B1 genes were constitutively 
Expression of CYP1B1 in human tissues
In primary fibroblasts, basal expression of CYP1A1 and Expression of CYP1B1 was first studied by qualitative RT-CYP1B1 mRNAs was detected at a slightly higher level than PCR in several human adult and fetal tissues. CYP1B1 mRNA in the JEG-3 cells. This basal expression level, however, was was found to be widely distributed in both adult and fetal still very low and did not result in detectable enzymatic tissues (Table II) . In adult liver, CYP1B1 was only weakly activities. TCDD treatment elevated CYP1A1 mRNA up to detectable, even after an extensive 35 cycle PCR amplification 12-fold in fibroblasts. CYP1B1 mRNA was expressed at a (Figure 1) , and could be detected after 25 cycles in only one stable, basal level despite TCDD exposure ( Figure 5 ). EROD, sample (data not shown), indicating a very low level of ECOD and AHH activities were below the level of detection, expression. In the lung samples, CYP1B1 mRNA was below even after the highest TCDD dose (data not shown). the level of detection, indicating lack of constitutive expression Placental Ah receptor and ARNT (Table II) . CYP3A5 mRNA could be detected from these lung samples, verifying the high quality of the cDNA (data not A quantitative RT-PCR method was developed for the determination of expression levels of Ah receptor and ARNT in shown). All the endometrium and lymphocyte samples were positive for CYP1B1 mRNA. Only four of the 10 bronchohuman placenta. Seven full-term and three first trimester placentas were used in this study. A large variation was alveolar lavage samples were positive, two of them, however, produced very strong PCR amplification results (Table II) .
observed in the level of Ah receptor expression ( Figure 6 ). There was a 210-fold difference between the highest and In fetal liver, CYP1B1 was weakly detectable in three out of six samples. All the extrahepatic fetal tissues studied were lowest mRNA levels. Compared with the Ah receptor, there was a relatively uniform expression pattern of ARNT in all positive, brain and kidney especially showing a higher level of expression than the other tissues (Table II and Figure 1) . samples, with an 18-fold difference between the highest and only a minor effect on Ah receptor and ARNT expression ( Figure 7 ).
Discussion
CYP1B1 was found to be constitutively expressed in many human adult and fetal tissues. This expression pattern is quite similar to that described for CYP1A1 (Table II) . In the liver, CYP1B1 was usually detectable only after 35 PCR cycles. According to our earlier experience, all major hepatic CYP forms can be detected by RT-PCR after 25 amplification cycles (16) . Although the amplification efficiencies of distinct primer pairs affect the final product yields, the lack of hepatic CYP1B1 detection after 25 cycles suggests that this form is expressed only at a very low level in the majority of livers. This finding is consistent with the lack of CYP1B1 in the HepG2 cell line (8). Liehr et al. have suggested that CYP1B1 mediates estradiol 4-hydroxylation in uterine myometrium and myoma tissues (7) . In this study CYP1B1 was found in every endometrium sample, supporting the idea that CYP1B1 may possess an important metabolic role in the uterus. It would be important to elucidate if endometrial CYP1B1 is involved in the metabolic activation of tamoxifen to DNA-reactive species, as endometrium seems to be a human target tissue for tamoxifen carcinogenesis (25) . Lymphocytes also showed some detectable mRNA and may therefore serve as a useful, easily accessible model for further studies. Of special interest was the relatively abundant expression of CYP1B1 in a minority of the broncho- activation of procarcinogens in target tissues in situ (such as the endometrium) or in tissues in direct contact with target tissues (such as alveolar macrophages in lung). lowest mRNA levels ( Figure 6 ). Maternal smoking did not affect Ah receptor or ARNT levels and a low level of Ah Consistent with the findings in adult liver, CYP1B1 mRNA was detected only in a minority of fetal livers at low levels. receptor seemed to be sufficient for high CYP1A1 induction (placentas 91/6 and 91/8).
In contrast, fetal extrahepatic tissues appeared to be major sites of expression. Fetal kidney and brain especially produced To further confirm that Ah receptor ligands do not affect expression of the Ah receptor or ARNT in placental cells, the consistently abundant PCR amplification products, suggesting that these tissues contain high CYP1B1 mRNA levels. While JEG-3 cell line was exposed to different concentrations of TCDD and Ah receptor and ARNT mRNA levels were in most tissues expression of CYP1B1 coincides with that of CYP1A1, the fetal kidney is an important exception (Table  measured . Expression levels of the Ah receptor and ARNT were close to each other in the JEG-3 cells and TCDD had II). Of all the tissues analyzed in the present study, CYP1B1 mRNA was detected at the highest level in fetal kidney, while CYP1A1 is almost totally absent in this tissue (26). The possible metabolic function of CYP1B1 in fetal kidney is currently unknown. The abundant expression of CYP1B1 in fetal extrahepatic tissues suggests that this CYP form may participate in the metabolism of endogenous substrates, perhaps with significance for fetal development. On the other hand, have purified a form of cytochrome P450 (HFLb) from fetal placenta, taken at day 16 of pregnancy, showed low Ah receptor expression and high ARNT expression (37). As this liver, which seems to belong to the CYP1 family but differs from CYP1A2 (27). A protein immunochemically related to low Ah receptor expression level in rat placenta is the opposite to what is known of human term placenta, it was of interest HFLb was also detected in fetal adrenal gland, kidney and lung (28). The relationship between HFLb and CYP1B1 has to study if this difference is due to species differences or whether the Ah receptor expression level is modulated by the not been characterized. The minimal expression of CYP1B1 in fetal liver and different apparent mobilities of CYP1B1 and stage of the gestation. The present study shows that in the human placenta, expresHFlb in SDS-PAGE suggest that HFLb is different from CYP1B1.
sion of Ah receptor and ARNT are independently regulated. There was a large interindividual variation in Ah receptor The present study shows that CYP1B1 mRNA is expressed constitutively in the placenta, albeit at a low level, both at the expression while no such difference was seen in ARNT. Recent findings indicate that the ARNT protein is capable of forming first trimester and at the end of pregnancy. We have previously shown that several CYP mRNAs can be detected from placenta homodimers and heterodimers with other bHLH/PAS factors than the Ah receptor (38,39). These complexes are able to by RT-PCR while only limited detection of the corresponding proteins was achieved (17). Placental estradiol 4-hydroxylase bind DNA motifs different from the XRE, which suggests that there is no reason to expect co-regulation of the Ah receptor activity is low and is mediated through NADPH-independent mechanisms (29), suggesting that no significant CYP1B1-and ARNT. The current finding that ARNT is expressed in a much less variable pattern than the Ah receptor suggests mediated enzymatic activity occurs in the placenta. Maternal cigarette smoking, however, preferentially increases 4-that ARNT posseses a vital function in the regulation of development and homeostasis of placental cells. Gestation hydroxylation, while having very little effect on 2-hydroxylation (12) . Induction of placental CYP1A1 by smoking is well time did not modulate expression of these factors and therefore the different relation of proteins observed in rat placenta (37) characterized (30,31). This study shows that placental CYP1B1 is not induced by maternal cigarette smoking and therefore it is probably due to species differences. Exposure of the placenta to cigarette smoke in vivo or TCDD exposure of cultured is unlikely that CYP1B1 is the inducible placental estradiol 4-hydroxylase.
JEG-3 cells did not significantly affect expression of the Ah receptor or ARNT. This is in good agreement with the lack of Induction of CYP1B1, like CYP1A1, is regulated through the Ah receptor (32). This study shows that these genes are Ah receptor and ARNT induction in other cell types (34,40), as well as with the housekeeping-type promoter region of the distinctly regulated in human placenta. CYP1A1 was also strongly induced by TCDD in the JEG-3 cell line, while Ah receptor gene (40,41).
In conclusion, the present data indicate that the CYP1B1 expression of CYP1B1 was unaffected. In fibroblasts, neither gene was inducible by TCDD. Although CYP1A1 mRNA was gene is expressed mainly in extrahepatic tissues in humans, including the fetus. Further study is needed to characterize the elevated by TCDD in fibroblasts, even this elevated mRNA level was still very low and did not result in detectable corresponding functional enzyme in these tissues. This is especially important since protein stabilization may also conenzymatic activity and this tissue may therefore be regarded as non-responsive, in agreement with an earlier study (24) .
tribute to regulation of CYP1B1 (32). The detection of CYP1B1 mRNA by RT-PCR in the present study will facilitate this Thus, the ability of the Ah receptor complex to stimulate transcription of the CYP1A1 and CYP1B1 genes appears to be work by guiding the direction of future studies. Further, CYP1B1 appears not to be induced by Ah receptor ligands in regulated in a tissue-specific manner. Non-responsiveness of CYP1A1 in fibroblasts seemed to be relative, perhaps because human placenta and is regulated independently from CYP1A1. Placental Ah receptor and ARNT are separately regulated and of the multiple xenobiotic-responsive elements (XRE) in the promoter region, while CYP1B1 showed more absolute lack their expression is not modulated by Ah receptor ligands. This study provides evidence that in addition to the Ah receptor, of induction. Cell-specific differential regulation of human CYP1A1 and CYP1B1 appears to be somewhat similar to that other cell-specific factors modulate the response of CYP1B1 and CYP1A1 to Ah receptor ligands. in animal models (33). Differential responsiveness of these genes in various breast cancer cell lines indicates that the estrogen receptor could be necessary for induction of CYP1A1
